May 23, 2026 - 11:23

GlobalFoundries Inc., a major player in the semiconductor industry, has announced the creation of a dedicated business unit aimed at advancing quantum computing. The new division, called Quantum Technology Solutions, was launched on May 21 and is designed to scale up domestic manufacturing for utility-scale quantum systems. This move marks the company's official entry into the next generation of high-performance computing.
The unit will focus on producing complete hardware solutions, including quantum processor units, cryogenic read-out integrated circuits, and advanced packaging. By offering these components, GlobalFoundries is positioning itself as a key supplier for the emerging quantum industry. The company aims to move beyond just making chips and instead deliver full hardware packages that can be used by quantum computing firms.
This initiative comes as the demand for specialized manufacturing grows. Quantum computers require extremely low temperatures and unique materials, which creates new challenges for chip fabrication. GlobalFoundries is betting that its experience in producing complex chips for other markets will give it an edge in this new field. The company sees quantum technology as a long-term growth opportunity, especially as governments and private companies invest heavily in the sector. With this new unit, GlobalFoundries is trying to secure a spot in what could be a major part of the computing industry in the coming decades.
September 30, 2026 - 01:50
Space Force Turns to Laser Systems to Shield Launch Sites from Drone ThreatsThe U.S. Space Force is moving forward with plans to deploy laser technology as part of a broader effort to defend its launch facilities from unauthorized drones. The initiative focuses on...
September 29, 2026 - 04:58
DIU Seeks Investors in Counter-Unmanned Systems TechnologyThe Defense Innovation Unit is looking for private investors to back companies working on counter unmanned systems technology. The effort targets firms building tools to detect, track, and disable...
September 28, 2026 - 02:02
Novo Nordisk (CPSE:NOVO B) Secures Long-Acting Injectable Technology In €1.165 Billion Nanexa Licensing AgreementNovo Nordisk has entered a global licensing agreement with Swedish drug delivery company Nanexa, valued at up to 1.165 billion euros. The deal centers on Nanexa`s PharmaShell technology, a platform...
September 27, 2026 - 08:32
New Biochip Enables Real-Time Tracking of Parkinson's Treatment ResponseResearchers have created a biochip technology that allows for real-time monitoring of how Parkinson`s disease patients respond to treatment. The development comes from a team working on advanced...